Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age.

Clinical and translational radiation oncology·2025
Same author

The use of a methylene blue and glyceryl trinitrate-based cream for the treatment of chronic anal fissures: a phase II randomized pilot trial from a referral coloproctological unit.

Techniques in coloproctology·2025
Same author

Correction: Consensus‑driven protocol for transanal irrigation in patients with low anterior resection syndrome and functional constipation.

Techniques in coloproctology·2025
Same author

Consensus-driven protocol for transanal irrigation in patients with low anterior resection syndrome and functional constipation.

Techniques in coloproctology·2024
Same author

Temporal trends and treatment patterns in anal fissure management: insights from a multicenter study in Italy.

Techniques in coloproctology·2024
Same author

Suture reinforcement using a modified cyanoacrylate glue to prevent anastomotic leak in colorectal surgery: a prospective multicentre randomized trial : The Rectal Anastomotic seaL (ReAL) trial.

Techniques in coloproctology·2024
Same journal

Robotic-assisted right colectomy with the DEXTER<sup>®</sup> Robotic Surgery System: first prospective multicenter study.

Techniques in coloproctology·2026
Same journal

A novel retro-muscular Sugarbaker technique for parastomal hernia prevention in end colostomy: combination of laparoscopic posterior component separation and extraperitoneal bowel pull-through-a prospective, single-arm study using the IDEAL framework.

Techniques in coloproctology·2026
Same journal

Single-stapled versus non-single-stapled colorectal anastomosis in minimally invasive anterior resections: a systematic review and meta-analysis.

Techniques in coloproctology·2026
Same journal

When nothing else matters: proctectomy for complex perianal Crohn's disease-indications, timing, techniques, and outcomes.

Techniques in coloproctology·2026
Same journal

Intermuscular dissection by transanal endoscopic operation for a rectal lesion.

Techniques in coloproctology·2026
Same journal

Predicting anatomical difficulty in robot-assisted rectal resection using a novel anatomic landmark-based grading system: a prospective observational study.

Techniques in coloproctology·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

In vitro Functional Characterization of Mouse Colorectal Afferent Endings
14:09

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

Published on: January 21, 2015

Sacral neuromodulation for bowel dysfunction: a consensus statement from the Italian group.

E Falletto1, E Ganio, G Naldini

  • 1Department of Surgery, Città della Scienza e della Salute, San Giovanni Battista Hospital, Corso Bramante 88, Turin, Italy, ezio.falletto@tin.it.

Techniques in Coloproctology
|April 9, 2013
PubMed
Summary
This summary is machine-generated.

Italian experts reached a national consensus on sacral neuromodulation (SNM) for bowel dysfunction, establishing guidelines for patient selection, management, and treatment protocols.

More Related Videos

In Vitro Recording of Mesenteric Afferent Nerve Activity in Mouse Jejunal and Colonic Segments
10:32

In Vitro Recording of Mesenteric Afferent Nerve Activity in Mouse Jejunal and Colonic Segments

Published on: October 25, 2016

Related Experiment Videos

Last Updated: May 12, 2026

In vitro Functional Characterization of Mouse Colorectal Afferent Endings
14:09

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

Published on: January 21, 2015

In Vitro Recording of Mesenteric Afferent Nerve Activity in Mouse Jejunal and Colonic Segments
10:32

In Vitro Recording of Mesenteric Afferent Nerve Activity in Mouse Jejunal and Colonic Segments

Published on: October 25, 2016

Area of Science:

  • Gastroenterology and Urology
  • Neuromodulation Therapies
  • Clinical Practice Guidelines

Background:

  • Italian centers experienced in sacral neuromodulation (SNM) convened to standardize clinical practice for bowel dysfunction.
  • The goal was to develop a consensus statement on SNM indications and patient management strategies.

Purpose of the Study:

  • To define current clinical practice for SNM in Italy.
  • To produce a consensus statement on SNM indications and patient management.
  • To establish national guidelines for SNM in bowel dysfunction.

Main Methods:

  • A questionnaire on SNM clinical practice was distributed to 50 Italian colonproctologists.
  • Expert opinions were gathered using a 5-point Likert scale, with data weighted by experience.
  • A follow-up meeting and literature review were conducted to reach agreement on critical aspects.

Main Results:

  • The study reviewed patient selection, diagnostics, implantation, follow-up, and result evaluation for SNM.
  • An algorithm for patient management in bowel dysfunction was developed.
  • Strategies for managing treatment failure were discussed.

Conclusions:

  • Substantial national consensus was achieved on key aspects of SNM therapy for bowel dysfunction.
  • The recommendations serve as national guidelines.
  • These guidelines are relevant for international SNM implantation centers.